SLC5A5 and thyroid gland carcinoma: Clinically, one of the crucial reasons for higher mortality of some thyroid cancer patients is their resistance to 131-I treatment in course of reduced radioidine uptake due to absence/decrease of the sodium-iodide symporter NIS expression [3].